InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,995.54
(
0.38%
)
US TECH 100
20,562.00
(
0.10%
)
Dow Jones
43,988.99
(
0.59%
)
Brent Oil
73.89
(
0.00%
)
Bitcoin
76,685.72
(
0.15%
)
Post# of 3412
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120698
Boards Moderated 13
Alias Born 09/05/2002

DewDiligence

Member Level

Re: vinmantoo post# 2452

Wednesday, 04/05/2023 10:05:16 AM

Wednesday, April 05, 2023 10:05:16 AM

Post# of 3412
GILD’s Obeldesivir* is an oral prodrug of Remdesivir. Hence, the efficacy of (IV-administered) Remdesivir, which is mediocre at best, would seem to be an upper bound on what GILD can hope Obeldesivir will achieve.

* f/k/a GS-5245.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ENTA News
More ENTA News
InvestorsHub NewsWire

SANUWAVE Announces Record Quarterly Revenues:  Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM

DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM

SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM

Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM

SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM

VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM

Start posting your company's news
Only $200 per official company press release!